Literature DB >> 2908896

Experimental increase of neurofilament transport rate: decreases in neurofilament number and in axon diameter.

S Monaco1, L Autilio-Gambetti, R J Lasek, M J Katz, P Gambetti.   

Abstract

In 2,5-hexanedione (2,5-HD)-induced axonal neuropathy, the rate of neurofilament (NF) transport increases in optic axons. To test the prediction that increases in the rate of polymer transport in any one locality of the axon lead directly to a decrease in the number of NF in that locality, NF and microtubules (MT) were quantitatively analyzed in axonal cross sections. In 2,5-HD axons the number of NF was 38% of that in control axons while the number of MT was not significantly changed; it appears that the drug treatment decreases NF number in the proximal axon regions, most directly through an increase in rate of NF transport. In those regions, the cross-sectional areas of the 2,5-HD-treated axons were 45% smaller than those of control axons; although the axons had shrunk in diameter, they retained their normal cylindrical shapes as measured by the index of circularity. Reduced internal expansive forces in the axon, working in conjunction with the normal external compressive forces, appear to reduce the radius of the axon. Quantitative analyses demonstrated that the average and the maximum lateral spacings between NF-NF, NF-MT, and MT-MT were all 30% larger in 2,5-HD-treated axons than in control axons. This suggests that polymers are relatively free to move laterally away from one another and to fill the available space within the axon. These observations are not consistent with models wherein 2,5-HD acts to crosslink the NF into an immobile network that can no longer advance within the axon. Instead, it appears more likely that 2,5-HD acts selectively on the interaction between some NF and the slow transport mechanism to increase the rate of NF transport.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2908896     DOI: 10.1097/00005072-198901000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Cytoskeletal changes induced by 2,5-hexanedione on developing human neurons in vitro.

Authors:  G Moretto; S Monaco; M G Passarin; M D Benedetti; N Rizzuto
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  Quantitative alterations of S-100 protein and neuron specific enolase in the rat nervous system after chronic 2,5-hexanedione exposure.

Authors:  J E Karlsson; S Wang; L E Rosengren; K G Haglid
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

3.  Gamma-diketone axonopathy: analyses of cytoskeletal motors and highways in CNS myelinated axons.

Authors:  Lihai Zhang; Terrence Gavin; Anthony P DeCaprio; Richard M LoPachin
Journal:  Toxicol Sci       Date:  2010-06-16       Impact factor: 4.849

4.  Cytoskeletal-associated protein kinase and phosphatase activities from cerebral cortex of young rats.

Authors:  M S de Freitas; A G de Mattos; M M Camargo; C Wannmacher; R Pessoa-Pureur
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

5.  Axonal transport of class II and III beta-tubulin: evidence that the slow component wave represents the movement of only a small fraction of the tubulin in mature motor axons.

Authors:  P N Hoffman; M A Lopata; D F Watson; R F Luduena
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

6.  Brentuximab vedotin: axonal microtubule's Apollyon.

Authors:  S Mariotto; S Ferrari; M Sorio; F Benedetti; G Tridente; T Cavallaro; A Gajofatto; S Monaco
Journal:  Blood Cancer J       Date:  2015-08-28       Impact factor: 11.037

7.  Cytoskeletal organization of axons in vertebrates and invertebrates.

Authors:  Andreas Prokop
Journal:  J Cell Biol       Date:  2020-07-06       Impact factor: 10.539

8.  Slow axonal transport mechanisms move neurofilaments relentlessly in mouse optic axons.

Authors:  R J Lasek; P Paggi; M J Katz
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.